+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Live Attenuated Vaccine"

From
From
From
From
From
From
Shingles Vaccines - Global Strategic Business Report - Product Thumbnail Image

Shingles Vaccines - Global Strategic Business Report

  • Report
  • April 2025
  • 269 Pages
  • Global
From
Preventable Vaccines - Global Strategic Business Report - Product Thumbnail Image

Preventable Vaccines - Global Strategic Business Report

  • Report
  • April 2025
  • 391 Pages
  • Global
From
Porcine Vaccines - Global Strategic Business Report - Product Thumbnail Image

Porcine Vaccines - Global Strategic Business Report

  • Report
  • April 2025
  • 376 Pages
  • Global
From
Dengue Vaccine Market Opportunities and Strategies to 2034 - Product Thumbnail Image

Dengue Vaccine Market Opportunities and Strategies to 2034

  • Report
  • March 2025
  • 294 Pages
  • Global
From
Porcine Vaccine Market Report 2025 - Product Thumbnail Image

Porcine Vaccine Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Loading Indicator

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus. Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines. Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more